Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · CHIEF EXECUTIVE OFFICER | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 806,111 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 5,361 · Balance 806,111 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1 |
Reported balance
Holding disclosure · report date 2026-09-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1 F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,720 | $37.29 | $138,718.80 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 123,838 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.08 to $37.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,160 | $36.82 | $116,351.20 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 127,558 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.07 to $37.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,120 | $35.39 | $39,636.80 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 130,718 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 14,880 | $37.29 | $554,875.20 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,901 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.08 to $37.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 12,639 | $36.82 | $465,367.98 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,781 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.07 to $37.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,480 | $35.39 | $158,547.20 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,420 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:37 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-006067 · wf-form4_167779303478950.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,305 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-002777 · wf-form4_167589127139562.xml · derivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,256,515 Underlying: Common Stock · 2,305 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 576 | $35.28 | $20,321.28 |
DisclosureSEC source: 0001628280-23-002777 · wf-form4_167589127139562.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 131,838 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.04 to $35.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,305 | $35.28 | $81,320.40 |
DisclosureSEC source: 0001628280-23-002777 · wf-form4_167589127139562.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,900 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.04 to $35.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 2,305 | $3.95 | $9,104.75 |
DisclosureSEC source: 0001628280-23-002777 · wf-form4_167589127139562.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · derivative · entry 12 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,258,820 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 425 | $36.16 | $15,368.00 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 132,414 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.06 to $36.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,575 | $35.52 | $269,064.00 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 132,839 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.05 to $36.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,710 | $36.16 | $61,833.60 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,900 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.06 to $36.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 30,290 | $35.52 | $1,075,900.80 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,610 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.05 to $36.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · derivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,290,820 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,245 | $36.86 | $82,750.70 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 140,414 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.60 to $37.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,755 | $36.18 | $208,215.90 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 142,659 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.58 to $36.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,981 | $36.86 | $331,039.66 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,900 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.60 to $37.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 23,019 | $36.18 | $832,827.42 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,881 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.58 to $36.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:10 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 807 common shares acquired under the Issuer's employee stock purchase plan. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:26 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322,820 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:26 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,000 | $35.14 | $281,120.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 148,414 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:26 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 32,000 | $35.14 | $1,124,480.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,093 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:26 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:26 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 735 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · derivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,354,820 Underlying: Common Stock · 735 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:26 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 184 | $35.00 | $6,440.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 156,414 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:26 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 735 | $35.00 | $25,725.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,093 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:26 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 735 | $3.95 | $2,903.25 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:19 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 27,352 | $31.15 | $852,014.80 |
DisclosureSEC source: 0001628280-23-000458 · wf-form4_167295352782882.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,093 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,905 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355,555 Underlying: Common Stock · 25,905 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 40 | $41.41 | $1,656.40 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 156,598 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.37 to $41.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,077 | $40.58 | $165,444.66 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 156,638 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.32 to $41.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,359 | $39.95 | $94,242.05 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 160,715 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.305 to $40.305, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 160 | $41.41 | $6,625.60 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.37 to $41.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 16,307 | $40.58 | $661,738.06 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,605 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.32 to $41.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 9,438 | $39.95 | $377,048.10 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,912 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.305 to $40.305, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 25,905 | $3.95 | $102,324.75 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 18,175 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · derivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,381,460 Underlying: Common Stock · 18,175 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 40 | $42.00 | $1,680.00 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 163,074 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,504 | $39.29 | $176,962.16 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 163,114 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.18 to $40.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 160 | $42.00 | $6,720.00 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 18,015 | $39.29 | $707,809.35 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,605 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.18 to $40.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 18,175 | $3.95 | $71,791.25 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,920 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · derivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,399,635 Underlying: Common Stock · 3,920 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 980 | $39.19 | $38,406.20 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 167,618 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.12 to $39.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,920 | $39.19 | $153,624.80 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.12 to $39.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:12 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 3,920 | $3.95 | $15,484.00 |
DisclosureSEC source: 0001628280-22-028639 · wf-form4_166785551453049.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.